Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CPC Scientific DOTA-DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt) 0.5MG
SDP

Supplier:  CPC Scientific SOMA017A

Encompass

Somatostatin analog DOTA-conjugated for radiolabels such as gallium-67, gallium-68, indium-111, and yttrium-90. This peptide is a useful tool for tumor imaging in radionuclide therapy.SEQUENCE: DOTA-DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (trifluoroacetate salt)(Cys2 and 7 bridge)ONE-LETTER SEQUENCE: DOTA-fCYwKTCT-ol (C2&C7 bridge)MOLECULAR FORMULA: C65H90N14O19S2MOLECULAR WEIGHT: 1421.64STORAGE CONDITIONS: -20 5 CCAS REGISTRY NUMBER: [177943-89-4]SYNONYMS: DOTA-(Tyr3)-Octreotate, DOTATATE, DOTA-(Tyr3,Thr8)-Octreotide, DOTA-[Tyr3] Octreotide Acid (Octreotate)RESEARCH AREA: GastrointestinalREFERENCES:L.Kolby et al., Br. J. Cancer, 93, 1144 (2005)R.Valkema et al., J. Nucl. Med., 46, 83S (2005)M.de Jong et al., J. Nucl. Med., 46, 13S (2005)W.A.Breeman et al., Eur. J. Nucl. Med. Mol. Imaging, 30, 917 (2003)A.Capello et al., Cancer Biother. Radiopharm., 18, 761 (2003)Chinol, M. et al. Semin. Nucl. Med. 32,141(2002)De

Catalog No. 50-211-0442


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.